Neomorph
PrivateLast Round
Series B
Apr 13, 2026
Total Funding Raised
$209M
Company Overview
Neomorph is a biotechnology company specializing in targeted protein degradation through molecular glue technology to discover and develop medicines for previously undruggable targets, facilitating clinical project advancement for medical practitioners.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neomorph Comps
Public and private peers based on sector, stage, and business model.
Neomorph Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 13, 2026 | ||||
| Series A | Dec 22, 2020 | ||||
| Seed | Mar 31, 2020 |
Key People
Founding team and executive leadership
Neomorph Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Series B, Series A |
| Regeneron Ventures | Series B |
| Binney Street Capital | Series B |
| Alexandria Venture Investments | Series B |
| Longwood Fund | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 14, 2026
Partnering with the Center for Protein Degradation at Dana-Farber Cancer Institute.
- Apr 14, 2026
NEO-811 therapy details to be presented at AACR Annual Meeting.
Neomorph Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neomorph's valuation, stock price, and market status.
